https://blog.lifesciencenation.com/2026/10/27/hot-investor-mandate-us-based-fund-invests-1-3m-in-seed-and-series-a-life-sciences-digital-health-and-healthcare-services-companies-in-womens-health/Next Phase Newsletteren2026-10-27T16:35:31+00:00Hot Investor Mandate: US-Based Fund Invests $1–3M in Seed and Series A Life Sciences, Digital Health, and Healthcare Services Companies in Women’s Healthtechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/10/27/hot-investor-mandate-us-based-early-stage-life-sciences-investment-firm-backs-pre-seed-to-series-a-therapeutics-medtech-and-biotechnology-platforms/Next Phase Newsletteren2026-10-27T16:35:10+00:00Hot Investor Mandate: US-Based Early-Stage Life Sciences Investment Firm Backs Pre-Seed to Series A Therapeutics, MedTech, and Biotechnology Platformstechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/10/27/hot-investor-mandate-venture-philanthropy-fund-invests-250k-2m-in-early-stage-therapeutics-diagnostics-and-medical-technologies-addressing-neurological-conditions/Next Phase Newsletteren2026-10-27T16:34:44+00:00Hot Investor Mandate: Venture Philanthropy Fund Invests $250K-2M in Early-Stage Therapeutics, Diagnostics, and Medical Technologies Addressing Neurological Conditionstechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligencehttps://blog.lifesciencenation.com/2026/10/27/hot-investor-mandate-global-corporation-seeks-strategic-partnerships-with-novel-therapeutics-and-platform-technologies-across-cardiovascular-metabolic-and-pain-indications/Next Phase Newsletteren2026-10-27T16:34:19+00:00Hot Investor Mandate: Global Corporation Seeks Strategic Partnerships With Novel Therapeutics and Platform Technologies Across Cardiovascular, Metabolic, and Pain Indicationstechnology, health, AI, business, entrepreneurship, finance, investing, artificial-intelligence